Medtronic

Medtronic Invests USD 700 Million in Cornerstone Robotics, Wins Distribution Rights for Sentire Endoscopic Surgical Robot Outside the U.S.

Fineline Cube Sep 3, 2026

Medtronic (NYSE: MDT) announced a strategic partnership with Cornerstone Robotics, including a strategic investment of...

Company Deals

Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio

Fineline Cube Jun 15, 2026

Medtronic (NYSE: MDT) announced on June 12, 2026 the completion of its acquisition of Scientia...

Company Deals Medical Device

Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration

Fineline Cube Jun 4, 2026

Medtronic plc (NYSE: MDT) announced on June 3, 2026, strategic investments in two privately held...

Company Medical Device

Medtronic Submits FDA 510(k) Filings to Expand Hugo RAS System into General and Gynecologic Surgery, Adds LigaSure Maryland Instrument

Fineline Cube Jun 4, 2026

Medtronic plc (NYSE: MDT) announced on June 3, 2026, the submission of 510(k) premarket notifications...

Company

Medtronic Reports Strong Q4 and FY26 Results with 6.6% Organic Growth, Cardiac Ablation Solutions Surge 78%

Fineline Cube Jun 4, 2026

Medtronic plc (NYSE: MDT) announced financial results for its fourth quarter (Q4) and fiscal year...

Company Deals

Medtronic to Acquire SPR Therapeutics for $650 Million, Expanding Chronic Pain Management Portfolio

Fineline Cube May 21, 2026

Medtronic plc (NYSE: MDT) announced its intent to acquire SPR Therapeutics, Inc., a privately held...

Company Medical Device

Medtronic Secures CE Mark for Stealth AXiS Surgical System – Next-Generation Integrated Robotics Platform

Fineline Cube Apr 29, 2026

Medtronic plc (NYSE: MDT) announced it has received CE Mark approval for the Stealth AXiS...

Company Deals

Pulnovo Medical Secures $100M+ Oversubscribed Financing Led by Medtronic – PADN System for Pulmonary Hypertension Attracts Global Investor Consortium

Fineline Cube Apr 20, 2026

Pulnovo Medical, a Chinese pulmonary hypertension (PH) has secured over USD 100 million in an...

Company Medical Device

Medtronic’s Stealth AXiS Surgical System Gains FDA Approval for Cranial and ENT Procedures, Expanding Beyond Spine

Fineline Cube Mar 30, 2026

Medtronic plc (NYSE: MDT) announced it has received U.S. Food and Drug Administration (FDA) marketing...

Company Medical Device

Medtronic Completes First Penditure Implant in Greater Bay Area – Recapturable LAA Closure System Leverages HK‑Macao Access Policy

Fineline Cube Mar 20, 2026

Medtronic plc (NYSE: MDT) announced the first clinical implantation of its Penditure left atrial appendage...

Company Deals

Medtronic to Acquire CathWorks for $585M, Expand AI-Based FFRangio System

Fineline Cube Feb 4, 2026

Medtronic Inc. (NYSE: MDT) announced it will exercise its option to acquire Israel-based medical device company...

Company Deals

Medtronic and Precision Neuroscience Form First Brain‑Device Alliance to Access Neural Data

Fineline Cube Jan 20, 2026

Medtronic plc (NYSE: MDT) announced a partnership with Precision Neuroscience Corp., marking the first public alliance...

Policy / Regulatory

NHSA Launches 6th VBP Tender for Medical Consumables in China, Targeting Drug-Coated Balloons

Fineline Cube Jan 13, 2026

China’s National Healthcare Security Administration (NHSA) conducted the 6th volume-based procurement (VBP) tender for high-value...

Company Deals

MiniMed Diabetes Files for IPO, Seeking Nasdaq Listing as MMED

Fineline Cube Dec 22, 2025

Medtronic plc (NYSE: MDT) announced that its diabetes business, which will operate under the name MiniMed,...

Company Medical Device

Medtronic’s Prevail DCB Gains CE Mark for Expanded Coronary Disease Indications

Fineline Cube May 26, 2025

US-Irish firm Medtronic (NYSE: MDT) announced that its Prevail paclitaxel-coated percutaneous transluminal coronary angioplasty (PTCA)...

Company Medical Device

Medtronic Plans to Spin Off Diabetes Business into Publicly Traded Entity

Fineline Cube May 23, 2025

Medtronic plc (NYSE: MDT), the US-headquartered medical technology company, has unveiled plans to spin off...

Company

Medtronic Reports Q4 and FY2025 Results with Revenue Growth Across Key Segments

Fineline Cube May 22, 2025

US-Irish firm Medtronic (NYSE: MDT) released financial results for its fourth quarter (Q4) and fiscal...

Company Medical Device

Medtronic Submits 510(k) Applications for Interoperable Diabetes Management System

Fineline Cube Apr 25, 2025

US-Irish firm Medtronic plc (NYSE: MDT) has submitted twin 510(k) applications to the U.S. Food...

Company Medical Device

Medtronic Wins FDA Approval for Simplera Sync Sensor in MiniMed 780G System

Fineline Cube Apr 21, 2025

US-Irish medical technology firm Medtronic plc (NYSE: MDT) has secured marketing approval from the US...

Company Medical Device

Medtronic’s Implantable Defibrillator System Gains NMPA Approval in China

Fineline Cube Apr 18, 2025

China’s National Medical Products Administration (NMPA) has approved Medtronic’s (NYSE: MDT) endovascular implantable defibrillation electrode...

Medtronic

Medtronic Invests USD 700 Million in Cornerstone Robotics, Wins Distribution Rights for Sentire Endoscopic Surgical Robot Outside the U.S.

Medtronic Completes $550 Million Acquisition of Scientia Vascular to Strengthen Neurovascular Portfolio

Medtronic Makes Strategic ICE Catheter Investments to Strengthen Cardiac Ablation Leadership and Affera Ecosystem Integration

Medtronic Submits FDA 510(k) Filings to Expand Hugo RAS System into General and Gynecologic Surgery, Adds LigaSure Maryland Instrument

Medtronic Reports Strong Q4 and FY26 Results with 6.6% Organic Growth, Cardiac Ablation Solutions Surge 78%

Medtronic to Acquire SPR Therapeutics for $650 Million, Expanding Chronic Pain Management Portfolio

Medtronic Secures CE Mark for Stealth AXiS Surgical System – Next-Generation Integrated Robotics Platform

Pulnovo Medical Secures $100M+ Oversubscribed Financing Led by Medtronic – PADN System for Pulmonary Hypertension Attracts Global Investor Consortium

Medtronic’s Stealth AXiS Surgical System Gains FDA Approval for Cranial and ENT Procedures, Expanding Beyond Spine

Medtronic Completes First Penditure Implant in Greater Bay Area – Recapturable LAA Closure System Leverages HK‑Macao Access Policy

Medtronic to Acquire CathWorks for $585M, Expand AI-Based FFRangio System

Medtronic and Precision Neuroscience Form First Brain‑Device Alliance to Access Neural Data

NHSA Launches 6th VBP Tender for Medical Consumables in China, Targeting Drug-Coated Balloons

MiniMed Diabetes Files for IPO, Seeking Nasdaq Listing as MMED

Medtronic’s Prevail DCB Gains CE Mark for Expanded Coronary Disease Indications

Medtronic Plans to Spin Off Diabetes Business into Publicly Traded Entity

Medtronic Reports Q4 and FY2025 Results with Revenue Growth Across Key Segments

Medtronic Submits 510(k) Applications for Interoperable Diabetes Management System

Medtronic Wins FDA Approval for Simplera Sync Sensor in MiniMed 780G System

Medtronic’s Implantable Defibrillator System Gains NMPA Approval in China

You Missed

Hengrui Pharmaceuticals Wins NMPA Clinical Trial Approval for SHR‑1179 – First‑in‑Class Biological Candidate for Weight Management

Hualan Bio Wins NMPA Clinical Trial Approval for Novel Influenza mRNA Vaccine – China’s Vaccine Major Pushes into mRNA Platform

METiS Therapeutics Partners with Hengrui Pharma – Deploying AiTEM AI Formulation Platform at China’s Leading Drugmaker

Suzhou AsiFlyer Biotechnology Secures Exclusive Worldwide License from ShanghaiTech University for AI‑Designed Recombinant Botulinum Toxin Patent